EFPIA Disclosure Reports 2021 | Takeda Pharmaceutical
Takeda Disclosure Reports 2021
General Information
Industry Association: PHARMIG
Contact Us: cco.smbx.at-compliance-austria@takeda.com
Documentation
General Information
Industry Association: ARPharM
Contact Us: Cco.smbx.bg-transparencyBulgaria@takeda.com
Documentation
General Information
Industry Association: APME
Contact Us: ee-transparency.estonia@takeda.com
Documentation
General Information
Industry Association: SFEE
Contact Us: Cco.smbx.gr-TransparencyGreece@takeda.com
Documentation
Documentation
General Information
Industry Association: Farmindustria
Contact us: trasparenza@takeda.com
Documentation
General Information
Industry Association: AFA
Contact Us: lv-transparency.latvia@takeda.com
Documentation
General Information
Industry Association: IFPA
Contact Us: lt-transparency.lithuania@takeda.com
Documentation
General Information
Industry Association: FarmaBrand Nova
Contact Us: Rs-Transparency-Serbia@takeda.com
Documentation
General Information
Industry Association: ARPIM
Contact Us: Cco.smbx.ro-TransparencyRomania@takeda.com
Documentation
General Information
Industry Association: INOVIA
Contact Us: Rs-Transparency-Serbia@takeda.com
Documentation
General Information
Industry Association: Farmaindustria
Contact Us: ES_transparencia@takeda.com
Documentation
General Information
Industry Association: Scienceindustries
Contact Us: transparency-CH@takeda.com
Documentation
General Information
Industry Association: APRaD
Contact Us: kateryna.zabara@takeda.com
Documentation
Given the current situation in Ukraine, EFPIA decided to suspend the disclosure requirements in that country for the 2022 disclosure of 2021 data